KINSA HEALTH, LLC – Trademark Portfolio
Entity Type: 16
KINSA HEALTH, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include KINSA, FLUENCY, and HEALTHWEATHER. The owner is based in WILMINGTON, DE.
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
Showing of trademarks Trademarks
Trademark Classifications
KINSA HEALTH, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does KINSA HEALTH, LLC have?
KINSA HEALTH, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does KINSA HEALTH, LLC file in?
KINSA HEALTH, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are KINSA HEALTH, LLC's most well-known trademarks?
KINSA HEALTH, LLC's registered trademark portfolio includes well-known marks such as KINSA, FLUENCY, and HEALTHWEATHER. These are among 4 currently registered trademarks in the portfolio.
What is KINSA HEALTH, LLC's trademark registration success rate?
KINSA HEALTH, LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.